Leerink Partnrs Comments on Immunovant FY2030 Earnings
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Leerink Partnrs issued their FY2030 earnings per share (EPS) estimates for Immunovant in a note issued to investors on Thursday, May 29th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of $1.06 per share for the year. The consensus estimate for Immunovant’s current full-year […]
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Leerink Partnrs issued their FY2030 earnings per share (EPS) estimates for Immunovant in a note issued to investors on Thursday, May 29th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of $1.06 per share for the year. The consensus estimate for Immunovant’s current full-year […]
